Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
NCT06482307
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC)
Interventions
DIAGNOSTIC_TEST:
[18F]-olaparib PET scan
Sponsor
University Medical Center Groningen